Identification of Mycobacterium tuberculosis genes that mediate inhibition of the host cell IFN-beta signaling
介导宿主细胞 IFN-β 信号传导抑制的结核分枝杆菌基因的鉴定
基本信息
- 批准号:9901025
- 负责人:
- 金额:$ 22.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:ApoptoticBacteriaCell DeathCell LineCellsCessation of lifeComplementCosmidsDNADataDendritic CellsDetectionFutureGenesGenetic ScreeningGenomeGrowthIRF3 geneImmune responseIn VitroIndividualInfectionInflammasomeInterferon-alphaInterferon-betaInterferonsKnowledgeLeadLibrariesLuciferasesM. tuberculosis genomeMeasuresMediatingModelingMolecularMolecular AnalysisMusMycobacterium smegmatisMycobacterium tuberculosisPathway interactionsPhenotypePopulationProductionProteinsPublic HealthPublishingReporterReporter GenesResearchResourcesSeriesSignal TransductionSiteTestingTimeTuberculosisType I Epithelial Receptor CellVirulenceautocrinebasedrug developmentgain of functionimprovedin vivointerestloss of functionmacrophagemutantnew therapeutic targetnovelparacrinepathogenreceptorscreeningtuberculosis drugs
项目摘要
Abstract
It is estimated that about one third of the world’s population is latently infected with Mycobacterium tuberculosis
(Mtb). The 10 million annual new cases of tuberculosis resulting in about one million deaths further underline the
global public health impact of this pathogen. Mtb has developed a multitude of pathways to evade the host
immune response. For the most part, the molecular mechanisms of these host pathogen interactions are only
beginning to be understood. The premise of the current proposal is supported by a series of novel and
unpublished results which demonstrate that Mtb inhibits IFN-a/b-receptor (IFNAR)-mediated cell signaling which
results in improved intracellular growth of the bacteria. These findings thus describe a novel immunoevasion
pathway engaged by Mtb. The central hypothesis of this application is that genetic screens will be able to identify
the genes in Mtb important for inhibition of the IFNAR-mediated cell signaling. In Aim 1.1 we propose to execute
a “gain-of-function” genetic screen using M. smegmatis clones transfected with a Mtb-DNA cosmid library. This
approach has been successfully executed for two other screens by the PI’s lab. Next, in Aim 1.2 we describe
how the relevant Mtb gene out of the approximately 40 genes in one of the isolated cosmids will be identified.
Overall, we anticipate that the successful completion of the current project will generate at least one Mtb deletion
mutant deficient in inhibition of IFNAR-mediated cell signaling and potentially the knowledge of several other Mtb
regions that contain additional genes. These findings will be the basis for a competitive R01 application which
will propose to: 1) complete the identification of all of the Mtb genes involved in inhibition of IFN-β-mediated cell
signaling, 2) to use the mutants for detailed analysis of the molecular mechanisms of the inhibition and 3) to
characterize the importance of inhibiting IFNAR-mediated cell signaling for in vivo virulence of Mtb.
摘要
据估计,世界上约有三分之一的人口潜伏感染结核杆菌
(Mtb).每年新增1 000万例结核病病例,造成约100万人死亡,这进一步突出表明,
该病原体对全球公共卫生的影响。结核病已经发展出多种途径来逃避宿主
免疫反应在大多数情况下,这些宿主病原体相互作用的分子机制仅仅是
开始被理解。目前建议的前提是由一系列新颖和
未发表的结果表明Mtb抑制IFN-α/β受体(IFNAR)介导的细胞信号传导,
导致细菌的细胞内生长得到改善。因此,这些发现描述了一种新的免疫逃避
Mtb参与的途径。这项应用的核心假设是,基因筛选将能够识别
Mtb中对抑制IFNAR介导的细胞信号传导重要的基因。在目标1.1中,我们建议执行
使用M.用Mtb-DNA粘粒文库转染的耻垢病克隆。这
PI实验室已成功对另外两个屏幕执行了该方法。接下来,在目标1.2中,我们描述
如何鉴定一个分离的结核分枝杆菌中大约40个基因中的相关Mtb基因。
总的来说,我们预计当前项目的成功完成将产生至少一个Mtb删除
IFNAR介导的细胞信号传导抑制缺陷的突变体,并且可能对几种其他Mtb的知识缺乏
包含额外基因的区域。这些发现将成为竞争性R 01应用的基础,
本研究拟完成以下工作:1)完成所有参与IFN-β介导的细胞毒作用抑制的结核分枝杆菌基因的鉴定
信号传导,2)使用突变体详细分析抑制的分子机制,和3)
表征抑制IFNAR介导的细胞信号传导对于Mtb体内毒力的重要性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VOLKER BRIKEN其他文献
VOLKER BRIKEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VOLKER BRIKEN', 18)}}的其他基金
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
结核分枝杆菌对宿主细胞炎症小体的操纵
- 批准号:
10619641 - 财政年份:2021
- 资助金额:
$ 22.78万 - 项目类别:
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
结核分枝杆菌对宿主细胞炎症小体的操纵
- 批准号:
10296451 - 财政年份:2021
- 资助金额:
$ 22.78万 - 项目类别:
Manipulation of the host cell inflammasome by Mycobacterium tuberculosis
结核分枝杆菌对宿主细胞炎症小体的操纵
- 批准号:
10424569 - 财政年份:2021
- 资助金额:
$ 22.78万 - 项目类别:
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
结核分枝杆菌逃逸宿主细胞的分子机制
- 批准号:
10544327 - 财政年份:2019
- 资助金额:
$ 22.78万 - 项目类别:
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
结核分枝杆菌逃逸宿主细胞的分子机制
- 批准号:
10080702 - 财政年份:2019
- 资助金额:
$ 22.78万 - 项目类别:
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
结核分枝杆菌逃逸宿主细胞的分子机制
- 批准号:
10322367 - 财政年份:2019
- 资助金额:
$ 22.78万 - 项目类别:
Characterization of the ESX-5 secretome and its impact on virulence mechanisms of Mycobacterium tuberculosis
ESX-5 分泌组的表征及其对结核分枝杆菌毒力机制的影响
- 批准号:
9333513 - 财政年份:2017
- 资助金额:
$ 22.78万 - 项目类别:
Inhibition of the host cell AIM2 inflammasome by Mycobacterium tuberculosis
结核分枝杆菌对宿主细胞 AIM2 炎性体的抑制
- 批准号:
8720174 - 财政年份:2014
- 资助金额:
$ 22.78万 - 项目类别:
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery
用于药物溶解和递送的无环葫芦脲分子容器
- 批准号:
9033081 - 财政年份:2013
- 资助金额:
$ 22.78万 - 项目类别:
Acyclic Cucurbit n uril Molecular Containers for Drug Solubilization and Delivery
用于药物溶解和递送的无环葫芦脲分子容器
- 批准号:
8842940 - 财政年份:2013
- 资助金额:
$ 22.78万 - 项目类别:
相似国自然基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
- 批准号:81971557
- 批准年份:2019
- 资助金额:65.0 万元
- 项目类别:面上项目
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
- 批准号:51678163
- 批准年份:2016
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Cell Wall Formation in Rod Shaped Bacteria
杆状细菌细胞壁的形成
- 批准号:
BB/Y003187/1 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Research Grant
Did light dictate ancient diversification of phylogeny and cell structure in the domain bacteria?
光是否决定了细菌领域的古代系统发育和细胞结构的多样化?
- 批准号:
24H00582 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Conference: Symposium on the Immune System of Bacteria
会议:细菌免疫系统研讨会
- 批准号:
2349218 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Standard Grant
DNA replication dynamics in living bacteria
活细菌中的 DNA 复制动态
- 批准号:
23K25843 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Fellowship
Assembly of the matrix that supports bacteria living in biofilms
支持生活在生物膜中的细菌的基质的组装
- 批准号:
2468773 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Studentship
Manipulating two-component systems to activate cryptic antibiotic pathways in filamentous actinomycete bacteria
操纵双组分系统激活丝状放线菌中的神秘抗生素途径
- 批准号:
BB/Y005724/1 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Research Grant
CAREER: Interfacial behavior of motile bacteria at structured liquid crystal interfaces
职业:运动细菌在结构化液晶界面的界面行为
- 批准号:
2338880 - 财政年份:2024
- 资助金额:
$ 22.78万 - 项目类别:
Continuing Grant














{{item.name}}会员




